You are here

Coronavirus (COVID-19): Information on medicines and medical devices

The TGA is publishing the latest information about medicines and medical devices as it relates to COVID-19 on this page.

Please read the information below before contacting the TGA to see if your question is already answered.

14 April 2021
The granting of a provisional determination means that the TGA has made a decision that GSK is now eligible to apply for provisional registration for the treatment in the Australian Register of Therapeutic Goods.
13 April 2021
Second case of thrombosis with thrombocytopenia
9 April 2021
Updated safety advisory – rare and unusual blood clotting syndrome (thrombosis with thrombocytopaenia)
8 April 2021
Updated storage conditions for the Pfizer COVID-19 vaccine
8 April 2021
TGA has recently approved wider storage and transportation conditions for the Pfizer COVID-19 vaccine in Australia
2 April 2021
Australia’s vaccine safety and regulatory process is world class and people can be confident that vaccines approved for use are safe and effective.
2 April 2021
Some rare cases of thrombosis associated with thrombocytopenia have been reported overseas following the administration of COVID-19 Vaccine AstraZeneca.


Further information

Contact TGA Info

Tel: 1800 020 653

Note: we are currently experiencing a high volume of calls and emails. Please bear with us as we try to respond to queries as quickly as possible.

Department of Health

Coronavirus (COVID-19) health alert — for information and advice not specific to therapeutic goods.

Follow us